Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Horbinski

Showing results (111-120 of 209) with videos related to

Pageof 21
Sort By:
Nature Medicine|June 24, 2020
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomesFarshad Nassiri, Ankur Chakravarthy, Shengrui Feng, et al.
JCI Insight|February 1, 2022
PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosisDan Xu, Swati Bhattacharyya, Wenxia Wang, et al.
Acta Neuropathologica|July 10, 2012
Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomasBenjamin Ellezam, Brett J Theeler, Tobias Walbert, et al.
JCI Insight|February 3, 2026
Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastomaRimas V Lukas, Ruochen Du, Harrshavasan Congivaram, et al.
Oncoimmunology|February 7, 2019
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg <i>et al</i>. (2017)Lijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Cell Metabolism|June 20, 2020
Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative StressXiang Cheng, Feng Geng, Meixia Pan, et al.
Cancers|November 13, 2025
Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging StrategiesBobak F Khalili, Michael R Chojnacki, Karan Dixit, et al.
Cell Reports|January 25, 2026
SREBP-1 upregulates SOAT1 to promote tumor growth by preventing lipotoxicityYaogang Zhong, Logan Mazik, Huali Su, et al.
The Journal of Molecular Diagnostics : JMD|May 23, 2022
Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System TumorsLucas Santana-Santos, Kwok Ling Kam, David Dittmann, et al.
Journal of Neuro-Oncology|June 12, 2024
Long-term outcomes of central neurocytoma - an institutional experienceYufan Yang, Nitin Wadhwani, Aoi Shimomura, et al.
Pageof 21

Showing results (111-120 of 209) with videos related to

Sort By:
Pageof 21
Nature Medicine|June 24, 2020
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomesFarshad Nassiri, Ankur Chakravarthy, Shengrui Feng, et al.
JCI Insight|February 1, 2022
PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosisDan Xu, Swati Bhattacharyya, Wenxia Wang, et al.
Acta Neuropathologica|July 10, 2012
Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomasBenjamin Ellezam, Brett J Theeler, Tobias Walbert, et al.
JCI Insight|February 3, 2026
Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastomaRimas V Lukas, Ruochen Du, Harrshavasan Congivaram, et al.
Oncoimmunology|February 7, 2019
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg <i>et al</i>. (2017)Lijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Cell Metabolism|June 20, 2020
Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative StressXiang Cheng, Feng Geng, Meixia Pan, et al.
Cancers|November 13, 2025
Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging StrategiesBobak F Khalili, Michael R Chojnacki, Karan Dixit, et al.
Cell Reports|January 25, 2026
SREBP-1 upregulates SOAT1 to promote tumor growth by preventing lipotoxicityYaogang Zhong, Logan Mazik, Huali Su, et al.
The Journal of Molecular Diagnostics : JMD|May 23, 2022
Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System TumorsLucas Santana-Santos, Kwok Ling Kam, David Dittmann, et al.
Journal of Neuro-Oncology|June 12, 2024
Long-term outcomes of central neurocytoma - an institutional experienceYufan Yang, Nitin Wadhwani, Aoi Shimomura, et al.
Pageof 21